Association Between Optimal Revascularization for Chronic Total Occlusion and Long‐Term Outcomes in Patients With Heart Failure With or Without Type 2 Diabetes
Journal of the American Heart Association · 21.07.2026 · 15 (14)
DOI: 10.1161/jaha.126.051797 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 21.07.2026. Verfasst von Yanjun Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cardiometabolic Medicine Center Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Med…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Heart Failure, Coronary Occlusion, Percutaneous Coronary Intervention. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus, Herzinsuffizienz
Abstract (Originalsprache)
Background
The relationship between optimal revascularization for chronic total occlusion (CTO) lesions and long‐term clinical outcomes in patients with heart failure with or without type 2 diabetes (T2D) remains unclear. Therefore, this study aimed to investigate the association between optimal or nonoptimal CTO percutaneous coronary intervention (CTO‐PCI) and long‐term adverse clinical outcomes in patients with heart failure with or without T2D.
Methods
This prospective cohort study included 1591 patients with heart failure who underwent CTO‐PCI at Fuwai Hospital between January 2017 and December 2018. Patients were categorized based on CTO‐PCI outcomes: failure, suboptimal revascularization, and optimal revascularization. The primary end point was a composite of cardiovascular death and target‐vessel myocardial infarction (TVMI), whereas the secondary end point was a composite of all‐cause death and myocardial infarction.
Results
During a median follow‐up of 3.3 years, 89 (5.6%) cases of cardiovascular death/TVMI occurred. Patients who received optimal revascularization had significantly lower risks of both cardiovascular death/TVMI (hazard ratio [HR], 0.45 [95% CI, 0.27–0.76]) and all‐cause death/myocardial infarction (HR, 0.53 [95% CI, 0.33–0.86]) compared with those with CTO‐PCI failure. Subgroup analysis showed that these associations were significant in patients with T2D (cardiovascular death/TVMI: HR, 0.25 [95% CI, 0.13–0.49]; all‐cause death/myocardial infarction: HR, 0.28 [95% CI, 0.15–0.53]), but not in those without T2D (cardiovascular death/TVMI: HR, 0.87 [95% CI, 0.32–2.40]; all‐cause death/myocardial infarction: HR, 1.06 [95% CI, 0.40–2.85]).
Conclusions
Our findings suggest that optimal revascularization during CTO‐PCI is associated with a lower risk of adverse cardiovascular events in patients with heart failure, particularly in those with T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiometabolic Medicine Center Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
- State Key Laboratory of Cardiovascular Disease Beijing China.
- Emergency Center Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
ORCID-Profile: Zhangyu Lin, Rui Fu, Kefei Dou
Zitieren
APA
Song, Y., Lin, Z., He, J., Fu, R., & Dou, K. (2026). Association Between Optimal Revascularization for Chronic Total Occlusion and Long‐Term Outcomes in Patients With Heart Failure With or Without Type 2 Diabetes. Journal of the American Heart Association, 15(14). https://doi.org/10.1161/jaha.126.051797
Vancouver
Song Y, Lin Z, He J, Fu R, Dou K. Association Between Optimal Revascularization for Chronic Total Occlusion and Long‐Term Outcomes in Patients With Heart Failure With or Without Type 2 Diabetes. Journal of the American Heart Association. 2026;15(14). doi:10.1161/jaha.126.051797
BibTeX
@article{Song2026,
author = {Song, Yanjun and Lin, Zhangyu and He, Jining and Fu, Rui and Dou, Kefei},
title = {Association Between Optimal Revascularization for Chronic Total Occlusion and Long‐Term Outcomes in Patients With Heart Failure With or Without Type 2 Diabetes},
journal = {Journal of the American Heart Association},
year = {2026},
volume = {15},
number = {14},
doi = {10.1161/jaha.126.051797}
}
EUVIMED